Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 426,454 | 258,215 | 154,080 | 80,943 | 42,220 |
| Cost of Goods | 206,901 | 169,273 | 118,815 | 79,770 | 61,291 |
| Gross Profit | 219,553 | 88,942 | 35,265 | 1,173 | -19,072 |
| Operating Expenses | 81,471 | 67,583 | 75,445 | 60,317 | 46,135 |
| Operating Income | 138,983 | 21,632 | -39,365 | -58,374 | -64,915 |
| Interest Expense | 13,930 | 25,027 | 19,279 | 13,057 | 11,985 |
| Other Income | 661 | -24,844 | -7,260 | -217 | 1,151 |
| Pre-tax Income | 125,714 | -28,239 | -65,904 | -71,648 | -75,749 |
| Income Tax | -71,959 | N/A | N/A | N/A | N/A |
| Net Income Continuous | 197,673 | -28,239 | -65,904 | -71,648 | -75,749 |
| Net Income | $197,673 | $-28,239 | $-65,904 | $-71,648 | $-75,749 |
| EPS Basic Total Ops | 0.85 | -0.13 | -0.33 | -0.51 | -0.88 |
| EPS Basic Continuous Ops | 0.85 | -0.13 | -0.33 | -0.51 | -0.88 |
| EPS Diluted Total Ops | 0.81 | -0.13 | -0.33 | -0.51 | -0.88 |
| EPS Diluted Continuous Ops | 0.81 | -0.13 | -0.33 | -0.51 | -0.88 |
| EPS Diluted Before Non-Recurring Items | 0.49 | 0.00 | -0.30 | -0.51 | -0.88 |
| EBITDA(a) | $147,836 | $32,415 | $-29,993 | $-51,124 | $-59,333 |